Transcatheter aortic valve implantation (TAVI) has been established as a treatment option for severe symptomatic aortic stenosis (AS) [
1]. Although TAVI effectively improves the survival rate of patients with severe AS, a major problem associated with its use is the high incidence of stroke following the procedure [
2]. Jakobsen et al. reported that the stroke rate in patients 0–90 days after TAVI was significantly higher than that of the general population (2.5% vs 0.5%) [
3]. Thus, a strategy for avoiding or minimizing stroke after TAVI in the short term is required. …